GVS advice CGRP inhibitors erenumab, fremanezumab, galcanezumab (Aimovig®, AJOVY®, Emgality®) for the treatment of patients with episodic and chronic migraine
de boer J, Wijma S
Record ID 32018002683
Dutch
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2021/09/17/gvs-advice-cgrp-inhibitors
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Migraine Disorders
- Calcitonin Gene-Related Peptide Receptor Antagonists
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
Keywords
- CGRP inhibitor erenumab
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.